Material review is a critical function of the Medical Affairs team in pharmaceutical companies. About 5% to 10% of FDA submissions are delayed every year because of MLR review. What are the challenges faced by MLR review teams in the era of data explosion? To learn more, download our POV on Promotional Material Review – Headed in the Right Path?